Product Information
QUETIAPINE ER 300 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.2672 per EA under NDC 68001060106. Its NADAC has been published 133 times since Dec 13, 2023.
Strength
300 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001060106
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA215478On Market Since
11/1/2023
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 300 MG TABLET has been published 133 times since Dec 13, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2672 per EA |
|---|---|
| All-time high | $0.3119 (Apr 10, 2024) |
| All-time low | $0.1954 (Nov 20, 2024) |
| 52-week high | $0.2827 |
| 52-week low | $0.2559 |
| Median price | $0.2698 |
| Average price | $0.2669 |
| Largest weekly change | +47.7% (Aug 21, 2024) |
| Weeks tracked | 133 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 300 MG TABLET, manufactured by BluePoint Laboratories, is $0.2672 per EA (NDC 68001060106), effective Jun 24, 2026.
How has the price of QUETIAPINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 300 MG TABLET has held within roughly two percent of its current level. It has been tracked across 133 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 300 MG TABLET?
Since Dec 13, 2023, the NADAC for QUETIAPINE ER 300 MG TABLET has ranged from a low of $0.1954 (Nov 20, 2024) to a high of $0.3119 (Apr 10, 2024), with a median of $0.2698 per EA.
Are there cheaper alternatives to QUETIAPINE ER 300 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1330 per EA — about 50% below QUETIAPINE ER 300 MG TABLET.
Who manufactures QUETIAPINE ER 300 MG TABLET?
QUETIAPINE ER 300 MG TABLET (NDC 68001060106) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification